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Résumé en
anglais
Initially, gene therapy was viewed as an approach for treating hereditary diseases,
but its potential role in the treatment of acquired diseases such as cancer is now
widely recognized. The understanding of the molecular mechanisms involved in
cancer and the development of nucleic acid delivery systems are two concepts that
have led to this development. Systemic gene delivery systems are needed for
therapeutic application to cells inaccessible by percutaneous injection and for multi-
located tumor sites, i.e. metastases. Non-viral vectors based on the use of cationic
lipids or polymers appear to have promising potential, given the problems of safety
encountered with viral vectors. Using these non-viral vectors, the current challenge
is to obtain a similarly effective transfection to viral ones. Based on the advantages
and disadvantages of existing vectors and on the hurdles encountered with these
carriers, the aim of this review is to describe the "perfect vector" for systemic gene
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